lanadelumab
Showing 1 - 10 of 10
Hereditary Angioedema (HAE) Trial in China (Lanadelumab)
Recruiting
- Hereditary Angioedema (HAE)
- Lanadelumab
-
Guangzhou, Guangdong, China
- +3 more
Jul 13, 2022
Lanadelumab in Participants With Hereditary Angioedema
Recruiting
- Hereditary Angioedema (HAE)
- Lanadelumab
-
Tokyo, T, JapanTakeda selected site
Jun 22, 2022
Healthy Volunteers Trial in Lincoln (Lanadelumab, Placebo)
Completed
- Healthy Volunteers
- Lanadelumab
- Placebo
-
Lincoln, NebraskaCelerion
Dec 14, 2021
Healthy Volunteers Trial in Cypress (Lanadelumab)
Completed
- Healthy Volunteers
- Lanadelumab
-
Cypress, CaliforniaWCCT Global, Inc.
May 13, 2021
Angioedema Trial in United States (Lanadelumab)
Recruiting
- Angioedema
- Lanadelumab
-
Birmingham, Alabama
- +7 more
Mar 30, 2022
Lung Injury Trial in Melbourne (Lanadelumab, Saline control)
Recruiting
- Lung Injury
- Lanadelumab
- Saline control
-
Melbourne, Victoria, AustraliaSt Vincent's Hospital Melbourne
May 4, 2022
Hereditary Angioedema (HAE) Trial in Japan (Lanadelumab)
Completed
- Hereditary Angioedema (HAE)
- Lanadelumab
-
Toyohashi-shi, Aichi-Ken, Japan
- +11 more
Sep 23, 2021
COVID-19 Pneumonia Trial (Lanadelumab, Placebo)
Withdrawn
- COVID-19 Pneumonia
- Lanadelumab
- Placebo
- (no location specified)
Oct 9, 2020
Hereditary Angioedema (HAE) Trial in Worldwide (Lanadelumab)
Available
- Hereditary Angioedema (HAE)
- Lanadelumab
-
Santa Monica, California
- +14 more
Oct 21, 2021